
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01058 | -3.36086404066 | 0.3148 | 0.349 | 0.291 | 1033930 | 0.31490321 | CS |
4 | -0.02878 | -8.64264264264 | 0.333 | 0.3499 | 0.25 | 1664306 | 0.29769694 | CS |
12 | 0.08172 | 36.7280898876 | 0.2225 | 0.447 | 0.22 | 2721769 | 0.34027437 | CS |
26 | 0.15782 | 107.800546448 | 0.1464 | 0.4945 | 0.1428 | 3023631 | 0.28734739 | CS |
52 | 0.15932 | 109.951690821 | 0.1449 | 0.4945 | 0.1031 | 2731907 | 0.21801594 | CS |
156 | -0.13578 | -30.8590909091 | 0.44 | 1.3 | 0.1031 | 2295447 | 0.26878193 | CS |
260 | -5.01578 | -94.2815789474 | 5.32 | 7.7 | 0.1031 | 2710985 | 1.48542813 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions